CIBC Asset Management Inc - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CIBC Asset Management Inc ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$208,000
-6.3%
1,870
+0.2%
0.00%0.0%
Q4 2020$222,000
+6.2%
1,867
+2.6%
0.00%0.0%
Q4 2019$209,000
-13.3%
1,820
-4.8%
0.00%0.0%
Q3 2019$241,000
+4.8%
1,9110.0%0.00%0.0%
Q2 2019$230,000
+5.0%
1,9110.0%0.00%0.0%
Q3 2018$219,000
-17.0%
1,911
-47.1%
0.00%
-50.0%
Q1 2018$264,000
+25.7%
3,6130.0%0.00%
+100.0%
Q4 2017$210,0003,6130.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2018
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders